Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Cytotoxin
    (5)
  • ADC Linker
    (1)
  • Drug-Linker Conjugates for ADC
    (4)
  • Endogenous Metabolite
    (4)
  • HIV Protease
    (2)
  • NF-κB
    (5)
  • STING
    (2)
  • Vasopressin Receptor
    (2)
  • cGAS
    (2)
  • Others
    (86)
Filter
Search Result
Results for "

dimer

" in TargetMol Product Catalog
  • Inhibitor Products
    108
    TargetMol | Activity
  • Recombinant Protein
    82
    TargetMol | inventory
  • Natural Products
    17
    TargetMol | natural
  • Peptides Products
    11
    TargetMol | composition
  • Inhibitory Antibodies
    2
    TargetMol | Activity
  • Dye Reagents
    2
    TargetMol | inventory
  • PROTAC Products
    2
    TargetMol | natural
  • Isotope products
    1
    TargetMol | composition
Oxytocin antiparallel dimer TFA
T81583
Oxytocin antiparallel dimer TFA is a homo peptide dimer connected by a disulfide bridge, exhibiting activities similar to oxytocin and vasopressin but with reduced toxicity [1] [2].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Vasopressin Dimer (parallel) (TFA)
T80197
Vasopressin Dimer (parallel) TFA, a parallel dimer of Vasopressin, has the capability to activate four G protein-coupled receptors—namely, V1aR, V1bR, V2R, and OTR [1].
  • Inquiry Price
Size
QTY
Oxytocin parallel dimer TFA
T78021
Oxytocin Parallel Dimer TFA, a disulfide-bridged homopeptide dimer, exhibits both oxytocin and vasopressin-like activity while being less toxic than oxytocin [1] [2].
  • Inquiry Price
Size
QTY
Oxytocin antiparallel dimer
T3942020054-93-7
Oxytocin antiparallel dimer is the disulfide-bridged homo peptide dimer.
  • $1,520
Backorder
Size
QTY
Vasopressin Dimer (anti-parallel) (TFA)
T80198
Vasopressin Dimer (anti-parallel) TFA, an anti-parallel dimer form of vasopressin, has the capability to activate four G protein-coupled receptors: V1aR, V1bR, V2R, and OTR [1].
  • Inquiry Price
Size
QTY
Oxytocin parallel dimer
T3938819645-28-4
Oxytocin parallel dimer is the disulfide-bridged homo peptide dimer.
  • $1,520
Backorder
Size
QTY
WL 47 - dimer
TP2102
High affinity caveolin-1 (CAV1) ligand (Kd = 23 nM); disrupts caveolin-1 oligomers. Exhibits selectivity for CAV1 over BSA, casein and HEWL.
  • $334
Backorder
Size
QTY
Amyloid-Forming peptide GNNQQNY
T83122339091-39-3
Amyloid-Forming peptide GNNQQNY, a biologically active heptapeptide derived from the N-terminal prion-determining domain of yeast Sup35, is instrumental in amyloid fibril formation. Its atomic oligomeric structure has been detailed, serving as an excellent model for investigating early-stage aggregation. The peptide can form three stable β-sheet structures: in-register parallel, off-register parallel, and anti-parallel. Notably, the in-register parallel dimer aligns closely with amyloid β-sheet architecture, relying on fewer interpeptide hydrogen bonds and emphasizing hydrophobic interactions, which enhances conformational entropy relative to the anti-parallel arrangement.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Mambalgin 1
TP20031609937-15-6
Selective ASIC1a inhibitor (IC50 values are 192 and 72 nM for human ASIC1a and ASIC1a/1b dimer, respectively). Binds to closed/inactive channel. Selective for ASIC1a over ASIC2a, ASIC3, TRPV1, P2X2, 5-HT3, Nav1.8, Cav3.2 and Kv1.2 channels. Increases late
  • $1,086
Backorder
Size
QTY
Glutathione oxidized
T1085L27025-41-8
Glutathione oxidized (L(-)-Glutathione) is a GLUTATHIONE dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized.
  • $39
In Stock
Size
QTY
Mambalgin 1 TFA
T75954
Mambalgin 1 TFA, a selective inhibitor of ASIC1a (with IC50 values of 192 nM for human ASIC1a and 72 nM for the ASIC1a/1b dimer), preferentially binds to the channel in its closed/inactive state. It demonstrates selectivity for ASIC1a over a range of other channels, including ASIC2a, ASIC3, TRPV1, P2X2, 5-HT3, Nav1.8, Cav3.2, and Kv1.2. In vivo, Mambalgin 1 TFA effectively prolongs the latency of the withdrawal response in mouse tail-flick and paw-flick tests.
  • Inquiry Price
Size
QTY